Managing and Reducing Uncertainty in an Emerging Influenza Pandemic, New England Journal of Medicine, vol.361, issue.2, pp.112-115, 2009. ,
DOI : 10.1056/NEJMp0904380
Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings, Science, vol.324, issue.5934, pp.1557-1561, 2009. ,
DOI : 10.1126/science.1176062
Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling, PLoS Medicine, vol.5, issue.6, 2009. ,
DOI : 10.1371/journal.pmed.1000275.s007
Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA, Influenza and Other Respiratory Viruses, vol.208, issue.1, pp.267-276, 2009. ,
DOI : 10.1111/j.1750-2659.2009.00106.x
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus, Science, vol.326, issue.5953, pp.729-733, 2009. ,
DOI : 10.1126/science.1177373
The New York City Swine Flu Investigation Team The severity of pandemic H1N1 influenza in the United States: a Bayesian analysis, PLoS Medicine, vol.6, 2009. ,
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong, Clinical Infectious Diseases, vol.51, issue.10, pp.1184-1191, 2010. ,
DOI : 10.1086/656740
Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study, PLoS Medicine, vol.361, issue.6, 2011. ,
DOI : 10.1371/journal.pmed.1000442.s009
Agespecific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation, PLoS ONE, vol.6, 2011. ,
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1, Health Technol Assess, vol.14, pp.115-192, 2009. ,
The Effective Reproduction Number of Pandemic Influenza, Epidemiology, vol.21, issue.6, pp.842-846, 2010. ,
DOI : 10.1097/EDE.0b013e3181f20977
School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong, Emerging Infectious Diseases, vol.16, issue.3, pp.538-541, 2009. ,
DOI : 10.3201/eid1603.091216
Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations, Journal of Clinical Microbiology, vol.49, issue.6, pp.2210-2215, 2011. ,
DOI : 10.1128/JCM.00229-11
2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore, JAMA, vol.303, issue.14, pp.1383-1391, 2009. ,
DOI : 10.1001/jama.2010.404
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study, The Lancet, vol.375, issue.9720, pp.1100-1108, 2010. ,
DOI : 10.1016/S0140-6736(09)62126-7
Reconstructing influenza incidence by deconvolution of daily mortality time series, Proceedings of the National Academy of Sciences, vol.106, issue.51, pp.21825-21829, 2009. ,
DOI : 10.1073/pnas.0902958106
Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus, Clinical and Vaccine Immunology, vol.18, issue.3, pp.520-522, 2011. ,
DOI : 10.1128/CVI.00449-10
A note on generation times in epidemic models, Mathematical Biosciences, vol.208, issue.1, pp.300-311, 2007. ,
DOI : 10.1016/j.mbs.2006.10.010
Appropriate Models for the Management of Infectious Diseases, PLoS Medicine, vol.30, issue.7, 2005. ,
DOI : 10.1371/journal.pmed.0020174.sd001
Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009, Clinical Infectious Diseases, vol.51, issue.3, pp.274-279, 2009. ,
DOI : 10.1086/653940
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial, The Lancet, vol.362, issue.9400, pp.1959-1966, 2003. ,
DOI : 10.1016/S0140-6736(03)15014-3
Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households, New England Journal of Medicine, vol.362, issue.23, pp.2175-2184, 2010. ,
DOI : 10.1056/NEJMoa0911530
URL : https://hal.archives-ouvertes.fr/pasteur-00588909
Implementation of the international health regulations (2005): report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza A (H1N1) 2009. Geneva: World Health Organization. Available: http://apps.who, 2011. ,
Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation, Vaccine, vol.28, issue.12, pp.2370-2384, 2010. ,
DOI : 10.1016/j.vaccine.2010.01.002
Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in Singapore, PLoS ONE, vol.167, issue.4, 2010. ,
DOI : 10.1371/journal.pone.0010036.s004
Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic, PLoS ONE, vol.7, issue.10, 2010. ,
DOI : 10.1371/journal.pone.0013211.s001
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong, Journal of Medical Virology, vol.101, issue.11, pp.1809-1815, 2010. ,
DOI : 10.1002/jmv.21895
Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus, PLoS ONE, vol.5 ,
URL : https://hal.archives-ouvertes.fr/pasteur-00782983
Cyclooctylamine of Experimental in the Prevention Human Influenza, JAMA: The Journal of the American Medical Association, vol.220, issue.6, pp.837-841, 1972. ,
DOI : 10.1001/jama.1972.03200060061011